Fallacy Dispelled: Invalidation Rates of Adjudicated Patents Convey Nothing About Quality of All Issued Patents

“Any suggestion that USPTO patent examination quality is a controlling factor in the high rate of patent invalidation in the district courts and at the PTAB is a fallacy that should be rejected and excised with prejudice from all discourse on USPTO examination quality.”

invalidationAbout half of the patents adjudicated in district courts and at the Patent Trial and Appeal Board (PTAB) are found invalid. It is shown here, however, that patent invalidity rates found in adjudication will necessarily range around the 50% point regardless of the underlying validity of the stock of all issued patents. Unfortunately, there are those who infer a fallacy from such adjudication statistics: that about half of all issued patents are also invalid.

Alarms should be raised when the U.S. Government Accountability Office (GAO) buys into this fallacy and adopts the rate at which the PTAB finds adjudicated patents invalid as a quality measure of all patents issued by the U.S. Patent and Trademark Office (USPTO). This is alarming particularly because some members of Congress have been misled by the GAO on this issue in recent hearings on the USPTO. Congress and the public have long relied on the GAO as an unimpeachable source of valid, unbiased, and reliable information to ensure the accountability of the federal government. When the GAO discards as unreliable the USPTO empirical quality data and relies instead on such fallacies to render its biased inferences, conclusions, and recommendations, it risks losing its credibility and the appearance of impartiality and objectivity.

Unfortunately, the GAO issued two reports that adopted this fallacious quality measure. These reports are titled “Information on Third-Party Funding of Patent Litigation,” issued December 5, 2024, and “Patent Office Should Strengthen Its Efforts to Address Persistent Examination and Quality Challenges,” issued on May 7, 2025. Therefore, it is now time to dispel this pervasive fallacy, and to that end, I filed with the GAO a formal request for correction of these two GAO reports. In the request, I explain in detail the critical errors of analysis, omission, and biased conclusions that undermine the reports’ objectivity and credibility. In this post, I address only one aspect of the reports’ infirmity — the patent quality fallacy.

Patent Validity is Adjudicated Only in a Special Selection of Disputes for Litigation

A patent holder’s loss rate on validity determinations at the PTAB or the district courts varies around the 50% rate, which has virtually nothing to do with the underlying actual quality of issued patents generally. Nor does this high invalidation rate in adjudication reflect the higher economic value of litigated patents, nor the patent challengers’ disproportionate resources amassed to invalidate patents. Rather, the reasons and factors that govern the outcomes of patent validity adjudications are solely reflective of the litigants’ divergent expectations in “close calls” that result in selection of only those special cases for litigation.

As in other adjudicated legal disputes, patent litigation normally arises and proceeds only when the parties do not settle their dispute based on rational evaluation of the quality of their respective positions. The Priest-Klein economic theory predicts that cases reaching trials cannot be, and are not, a random sample from the full range of possible probabilities of success of any given party. They are rather a narrow selection from those “close call” cases in which the uncertain merits indicate that opposing litigants each have about 50% prior probability of prevailing. Other cases in which both litigants after further investigation come to similar estimate of the likely outcome (on either side) are normally settled — they are not “selected” for litigation.

Priest and Klein show that plaintiff’s success rate in civil trials is invariant under the legal provisions, the deciding tribunal, the standard of the decision, or the underlying facts in dispute. Actual plaintiff success rate over an ensemble of multiple adjudicated cases can deviate up to 25% either way from the 50% point due to asymmetry between the opposing parties in prior information available to them, or their stakes in the outcome. This unique characteristic of cases selected for litigation has been empirically shown for essentially all categories of civil litigation. This is shown in Table 1 of my request for correction, showing that plaintiffs won in 54.8% of about 40,000 civil trials. For example, the empirical data in the table indicate that plaintiffs in labor law cases won in 49.2% of these adjudicated cases. Clearly, one cannot infer from this data that about half of all employment agreements were violated. Such inference would be clearly wrong, as are the inferences the GAO makes from the loss rates of patent holders in adjudicated patent cases.

The empirical results in patent cases follow similar patterns and variations. This conclusion also applies to post-issuance cases selected for litigation at the PTAB, where the challenged patents largely mirror the same patents in cases selected for litigation in District Courts.

About Half of Adjudicated Patents Will Be Consistently Found Invalid Even When Only a Few Percent of All Issued Patents May Actually Be Invalid

The figure below demonstrates a simplification of the Priest-Klein model in the context of patent litigation. For the sake of discussion, assume that 6% of issued patents are likely invalid, as depicted schematically in part (a) of the figure. Here, Q(x) is the ordered distribution of the prior probability that patents in that population percentile x (horizontal axis) are valid. Prior uncertainty of the validity of some patents is shown by the gray zone labeled “close calls,” which is expanded horizontally in the view of part (b).

 

Around the time that a patent from this large population is asserted or challenged, the holder of the patent and its challenger will each conduct a detailed investigation of the merits of their respective cases to refine and form their own respective perceived probability of their success. The divergence of their respective expectations of the outcome would typically arise only in uncertain cases in the narrow “close calls” range.

Part (b) in the figure schematically plots two additional probability curves, showing the probability of success in litigation as perceived by the patent challenger and by the patent holder respectively. These are shown as smooth curves, but in reality, these curves are fuzzy, as for each hypothetical patent in dispute along the x axis, the perceived probabilities may slightly vary based on differing specific information available to the parties. However, the plots capture the overall general trend with respect to the magnitude of the prior probability of validity Q(x). As shown in part (b), cases with disputed patents for which the patent holder and its challenger similarly perceive the likelihood of validity will be settled and not litigated. That is, when patents are likely valid, the probability of success as perceived by the patent holder is high, and low as perceived by the challenger. When patents are likely invalid, the probability of success as perceived by the patent holder is low, and high as perceived by the patent challenger. In both scenarios, there would be no appreciable divergence of expectations of the parties as to the outcome of the litigation and they will settle. In the former scenario, when patents are likely valid, settlement will perhaps involve the patent challenger paying restitution and/or taking a license; and in the latter scenario, when patents are likely invalid, the patent holder will perhaps disclaim certain patent claims or agree to withdraw the assertion of the patent. Therefore, the validity of the patents in both scenarios and their numbers will never be reflected in adjudications.

The result of this selection is shown in part (b) of the figure: disputes are selected for litigation only in “close call” cases where the parties’ internal assessment after further investigation diverge on the likely outcome — where there is substantial overlap of relatively high probability of success that each opposing party perceives. As I have shown elsewhere, that overlap has been for extremely small fraction of patent cases for over a century, during which less than two patents per 1,000 patents in force were selected for litigation. Upon commencement of litigation in those rare cases, subsequent discovery and briefing will narrow down the disagreement gap on the likely outcome, where it has been shown that only about 5.5% of litigated patent cases are ultimately adjudicated on the merits. This means that only about 1 out of 10,000 patents in force were adjudicated.

It follows that such narrow selection within these “close call” cases means that the validity of adjudicated patents has the highest prior uncertainty — near 50% prior probability of validity, as shown by the value of Q(x) in part (b) of the figure. Because such patent disputes also involve other legal and factual factors such as questions of infringement, asymmetries in the information available to the parties, or their stakes in the outcome, patent invalidation results may deviate from the 50% validity rate results but nevertheless will remain substantially high.

In conclusion, the patent invalidation rate in adjudication will be high (around the 50% point). However, that rate essentially conveys no information about the relative fraction of all issued patent percentiles below the “close calls” gray zone that are likely invalid, compared to those above this zone that are likely valid. This example shows that despite the fact that only 6% of issued patents are assumed invalid, about 50% of adjudicated patents will be found invalid. Simply stated, patents selected for adjudication are specifically from the transition zone between two distinct patent quality populations of unknown relative size. The GAO erroneously inferred their relative size from adjudication outcomes for patents in the uncertainty transition zone. This is a fatal error that dooms these conclusions to the dustbin.

Because a patent claim is a legal instrument defining legal boundaries of exclusivity based on the written words, it is essentially equivalent to a (private) statute. Just as disputes on statutory interpretation are central in other litigation under law, so do the majority of litigated patent disputes turn on claim interpretation, which is a question of law. Indeed, research shows that only 11% of litigated patent cases pass beyond the preliminary Markman claim construction adjudication phase to continue on to adjudication on the merits. Therefore, patent litigation often centers on matters on which USPTO examination could have had no effect. This includes questions whether claim terms are to be interpreted as covering after-arising technology, which no “thorough and rigorous” examination at the USPTO could have divined at the time of examination.

Any suggestion that USPTO patent examination quality is a controlling factor in the high rate of patent invalidation in the district courts and at the PTAB is a fallacy that should be rejected and excised with prejudice from all discourse on USPTO examination quality.

See the detailed explanation of this and other GAO errors in my formal request for correction.

 

Share

Warning & Disclaimer: The pages, articles and comments on IPWatchdog.com do not constitute legal advice, nor do they create any attorney-client relationship. The articles published express the personal opinion and views of the author as of the time of publication and should not be attributed to the author’s employer, clients or the sponsors of IPWatchdog.com.

Join the Discussion

11 comments so far.

  • [Avatar for Greg DeLassus]
    Greg DeLassus
    August 27, 2025 03:47 pm

    The PTAB’s “kill rate” is nothing like 70%. Properly measured it is much lower.

  • [Avatar for Greg Aharonian]
    Greg Aharonian
    August 27, 2025 03:33 pm

    Stephen writes:

    “It very clearly explains why the PTAB’s 70% patent kill rate does not indicate that 70% of all patents are invalid.”

    I will agree that the PTAB kill rate is not definitive evidence of an overall invalidity rate, for the simple reason of sample size. Assuming 2-3% of patents are litigated in all forums, that is a decent sample size, but there is too much sample bias. Crappy patents won’t be litigated, excellent patents won’t be ligitated, etc.

    But Ron’s is a decent sample, so one could reasonable conclude that at least half of all issued patents are invalid (do a bootstrap analysis if you want). From a Bayesian analysis point of view, it will confirm any similar measurement of invalidity.

    Supporting a >50% invalidity rate is my sample size across hundreds of thousands of (software) patents, for the statistic that >50% of such patents impossibly do not cite any non-patent prior art – an extremely strong attack for any patent.

    And there is the Finnegan white paper quoting analysts that up to 97% of all patents are worthless. And there is more ancedotal data (like some of the companies with the largest number of valid? patents having horrible stock performance across the decades).

    Which makes it eminently reasonable to conclude that >50% of all patents are invalid. Which hasn’t changed in the 30 years I have been researching patent validity. And the reasons haven’t changed as well: applicants don’t want to do prior art searches that will a priori suggest that they don’t file, patent lawyers don’t want their clients doing searches for the same reason, examiners have never had the time/resources to do prior art searchers, and worse, no one in Congress cares to demand an accurate measurement in this multi-billion dollar industry.

    I have made most of my living invalidating patents for litigation purposes. I don’t do much of a business with patentability searches, even though I am applying the same skills at a much lower cost. I don’t get the patentability work, not because people don’t think I can do a good job, but because people think I can do a good job. No one wants to know.

    So Ron’s PTAB statistics of 70% not only get us in the ballpark, but get us in the in-field from a Bayesian point of view. The majority of issued patents are invalid. And not just on prior art grounds.

    Many patents are riddled with (near)-fatal claim terms, or non-enabling definitions of important claim terms in the Specification. I once saw a huge family of patents where a nanowire’s width was basically defined as “from 0 nanometers to the width of the universe”. The inexperienced patent lawyer left out half of the definition of the term, with a cute definition, that rendered all of the patents invalid under 112.

    And the very nature of Markman claim construction should render any patent needing it – automatically invalid for lack of enablement. Think about it. The first lesson in patent drafting is that once a patent is filed, you can’t add new matter to the Specification (except for a CIP) – so get it write the first time. No new matter after filing.

    Claim construction effectively adds new matter to the Specification – the definitions that end up from claim construction. Which violates Due Process public notice at issuance, since those claim terms were not sufficiently enabled for the public without the added claim construction. The courts across civil law have been quite clear: you can’t be tried for a crime where the exact nature of the crime is determined at trial. That is what is Markman claim construction (same problem plagues copyright law – you don’t know what ‘idea’ and ‘expression’ are until a judge rules). Indeed, years ago, someone confronted a CAFC judge about this Due Process contradiction. The judge told him to go f&*^*^&*k himself. They know, but refuse to raise this issue of jurisprudence.

    So for these, and at least 20 other reasons (rules in my particular invalidity analyzer), across hundreds of thousands of patents, at least 50% of all issued patents are invalid. Ron’s analysis of 70% being found invalid by PTAB, in a Bayesian analysis, is supportive of other statistics. But I suspect Ron’s PTAB statistic is close at 70%. PTAB litigated patents aren’t the best, and aren’t the worst, but good enough to a) be triable, and b) have the defendant spend a lot of money to find invalidity evidence.

    But be it 97% (Finnegan), 80% (80 percent of everything is lousy), 70% (Ron/PTAB), >60% (Greg), 50%, 40% invalidity – this rate is way too high, and has been way to high for decades.

    And the strongest reason I believe it is over 60% is that none of the powers that be want to know what the real invalidity rate is. No one. For the last 30 years. The GAO tries, but it has no experts on patent analysis. Over $5 billion a year is spent on patent prosecution, and we don’t know even a decent quality rate (both invalidity and enforceability)? That’s professional?

    To the powers that be at IPWatchdog, how about an IPWatchdog seminar/conference on measuring patent quality/value? It is desperately needed, especially if the Trump administration wants to start taxing patent value. Everyone is going to rush to court arguing that their patent really isn’t that valid, and thus not that valuable, so no tax. Gee, new business for me!

  • [Avatar for Stephen Schreiner]
    Stephen Schreiner
    August 27, 2025 01:10 pm

    This is a fascinating analysis factoring in party selection behavior in choosing which patents to litigate to a final decision. “Rather, the reasons and factors that govern the outcomes of patent validity adjudications are solely reflective of the litigants’ divergent expectations in ‘close calls’ that result in selection of only those special cases for litigation.” Ron, I understand the premise is that patents will tend to be invalidated at about a 50% rate in the courts because only those patents that are close calls will be litigated. The patents that are plainly invalid will not be litigated. The patents that are plainly valid/infringed either will not be litigated (they will be licensed?) or they will be litigated but settled before a decision on validity. Is that about right?

    So the larger body of issued patents could be 90% valid or they could be 75% invalid. Either way, litigated decisions will find about 50% of litigated patents to be invalid.

    It very clearly explains why the PTAB’s 70% patent kill rate does not indicate that 70% of all patents are invalid. That said, I’m still not clear on why the PTAB has such a high kill rate (well over 50%). Something else is at work there…

  • [Avatar for Greg DeLassus]
    Greg DeLassus
    August 22, 2025 01:15 pm

    I clicked on this article with a skeptical presupposition, but by the end of the article I was convinced of the author’s thesis. Well argued, Dr. K, and thank you for this essay.

  • [Avatar for Greg Aharonian]
    Greg Aharonian
    August 21, 2025 09:57 pm

    Ron, you ask:

    “Just being curious: what percentage of the software patents you have been tasked to review were involved in a patent dispute? Can you really say that your experience was not selective of disputed questionable patents to begin with?”

    Good question. Over the decades, I have dealt with large numbers of three types of patents – patents being litigated, patents being insured against or insured for to be collateral, and randomly selected patents that I come across when I run each week’s new software patents through a comprehensive validity/enforceability/valuation analyzer I have been working for 10 years.

    At least 1000 patents in each category across 30 years. So with that many patents, coming to my attention for very different reasons, I doubt there is much of a selection bias. That is, for the 3000+ plus patents I have dealt with, if you randomly chose another 3000+ patents, there would not be much of a difference in the statistical distributions of their validity/enforceability/value.

    That is, my observations would apply to all (software) patents to a reasonable degree of statistical validity. There is no selection bias. I have invalidated software patents, dog flea collar patents, fermentation patents, cellphone patents (whacked away at the Blackberry portfolio), gene editing patents, quantum computing patents (all of the software patents of which are unenforceable), etc. Really doesn’t matter – no selection bias.

    Given this, I will repeat what I have said for 30 years. Given me $10,000 per patent, and I have-found/can-find invalidity prior art, and patent claim and specification defects, that render at least 80% of all software patent invalid or not enabled. The rest have to be narrowed to be only useful as defensive patents. I actually don’t charge that much per patent for litigation, but currently want to buy a new Harley, so a few extra grand would be nice :-). And in many cases, if a client insults me while discussing me working for them, I might be outraged enough to complete the invalidity search while we are talking.

    In fact, had I been searching in the 1970s, I could have found 102 prior art to invalidate Benson’s BCD algorithm, preventing the worst Supreme Court decision affecting patents for having to be written (though they would have found another case to write the same ‘abstract’ nonsense). The patent system has never been able to deal with computer science for decades.

    Don’t take me seriously because I am not a lawyer? Fine. In November 2021, the prestigious law firm Finnegan Henderson issued a white paper in which it cited with approval the following statistic: “There is a significant disconnect between the perspective of corporate executives and industry analysts who report that to 97% of patents fall into the low value category”. 97 freaking percent.

    https://www.finnegan.com/en/insights/articles/unicorn-patents.html

    So when I state similar percentages from 50% to 80%, I am actually being generous. What is hilarious about the Finnegan white paper is that the firm acquires such huge numbers of patents that by the Law of Large Numbers, up to 97% of the patents they prosecute are of low value.

    It is why $10,000 Patent Defense policies (which cover the costs of litigation AND damages if any) can be offered against all software patents at a profit for the insurance companies, as long as we can get back attorney’s fees. And thus why the vast majority of software patents are worthless (since they cost $40,000+ to acquire), and worthless at the moment they were filed.

    As I said earlier, the fact that over 50% of issued software patents cite nothing – zero – from the archives of the IEEE, ACM, SPIE, LNCS, Github, etc. – is reprehensible in this age of advanced search engines. What arrogance to assert that nothing in these extremely learned societies is relevant to your invention (most of which should be “improvement comprising” Jepson claimed, a practice that has vanished).

    And more reprehensible than the incredible lack of non-patent prior art citations, is that 30 years of me whining about this, and there has not been one serious investigation by the powers that be. No one, I say no one, at least for software patents, cares about patent validity/enforceability.

    Congress? Bad enough they wrote the unconstitutional statutes in the first place (‘process/abstract’, ‘obvious’, and ‘enabled’ all undefined in statute and Legislative history are prima facie unconstitutionally vague for violating Due Process). But Congress has never had a hearing on patent quality/validity where they have experts on patent quality/validity testify. The charade is also the same: a few PTO officials, a few patent world bigwigs, an academic who has never spent his or her own money getting a patent, some twit spouting discredited citations analysis, etc.

    Here is some more fun. There are fair number of companies with large numbers of ‘valid’ patents, that are publicly traded. Your IBMs, Toshibas, Intels, etc. For the last 20 years, their stock prices have much been flat, greatly underperforming the SPY and worse, underperforming gold (the anti-stupidity hedge). If there was so much real innovation at these companies, the best of which is protected by the ‘valid’ patents they obtain in droves, their stock prices would at least track SPY, if not outperform (some of the few companies with high quality patents and high quality stock returns are ASML and Synopsys, if you want examples).

    So yes, I have examined many thousands of software patents to the extent that there is no selection bias – the Law of Large Numbers applies. And yes, I will guarantee that for $10,000 per patent across large numbers of patents, I can find invalidity prior art or claim/specification defects, to render the patent invalid. Have been saying this for 30 years. Nothing has changed.

    Worse, nothing has changed in over 100 years. There is an old IEEE Proceedings Letter to the Editor in the 1910s, summarized as: “Sirs, are there any patent examiners or judges who understand electric motors? Why is our industry plagued with many dubious such patents?”

    For those of you who know me, all of the above has been pretty polite (for me). So grant me a snark: “Stop Drinking the Koolaid”.

  • [Avatar for Ron Katznelson]
    Ron Katznelson
    August 21, 2025 06:15 pm

    Greg,
    You say: “the fact that 50% of adjudicated (software) patents are found invalid – to me – is evidence of the reality that over 70% of software patents are invalid.”
    You are missing the point here. You apparently believe that invalidity rate in adjudication of software patents is a relevant metric different than for other subject matter — that such uninformative invalidity rate must be a lower bound to which one needs to add another 20% for software patents. That argument has no basis. Why not add 40%? Why not subtract 20%?

    Of course, in a matter unrelated to the topic of this article, as one who has decades of professional experience in debunking patents, you may state your observation of the reasons you believe that 70% of issued software patents are invalid. This may, or may not be true; but it would have nothing to do with the invalidity rate observed in adjudication, which reveal nothing about the validity of all other patents.

    Just being curious: what percentage of the software patents you have been tasked to review were involved in a patent dispute? Can you really say that your experience was not selective of disputed questionable patents to begin with?

  • [Avatar for Greg Aharonian]
    Greg Aharonian
    August 21, 2025 04:55 pm

    Ron,

    At least for software patents, the fact that 50% of adjudicated (software) patents are found invalid – to me – is evidence of the reality that over 70% of software patents are invalid. And the reason is quite simple – as I observed for over 30 years, the majority of software patents cite NO non-patent prior art, and over 90% cite inadequate amounts of prior art.

    Applicants are not doing so because they don’t want to spend the money, don’t want their inventions shown to be unpatentable, or aren’t told the importance of doing so. And examiners are not given enough time/resources to do thorough searches.

    I have a table of data about software patent prior art citations for the last four years (no different than the statistics from the early 2000s I used to publish), available at:

    https://shadowpatentoffice.co/DOCUMENTS/StatisticalProofWorthlessness.html

    Even today, despite incredibly powerful (AI-driven) search engines, over 50% of all software patents cite no non-patent prior art – laziness. To patent analysts and litigators, these are all juicy targets of invalidity attacks. To cite no non-patent prior art is to declare to the world that your invention is similar to nothing in the archives of the IEEE, ACM, LNCS, SPIE, Github, etc. That is an impossibility.

    It is why I am glad to work with insurance companies to offer a Patent Defense policy against individual software patents at a cost far lower than the cost to prepare/prosecute the patent – we know >70% of the time, we crush with prior art and get back attorney fees, and make a profit (the few losses are covered by the premium pool). And at this fractional premium cost, the patent is worthless at issuance (under the dynamics of insurance-backed litigation, if you can get lawsuit/damages protection for a far less cost than licensing).

    Another factor is that in light of a thorough prior art search, the claims have to be so greatly narrowed to have any validity as to be defensive patents only, and mostly useless to assert offensively (the infringer will be outside the scope). Thus, while valid in a limited way, the patent is mostly worthless.

    And another factor in being able to offer low-cost Defense policies is that most (software) patents are not enforceable, for multiple reasons. And if more litigators understood computer science (or hired software experts trained in 112), they would see a new attack angle – that most software patents are not enabled (take any random software patent and try to write functional code that is similar to the intent of the software invention – in a reasonable amount of time/money).

    I cannot believe that for 30+ years, this issue of the inadequate amounts of prior art cited in patents has gone unaddressed. And while my specialty is hardware/software/telecom (the Electronics section of the old Gazette – which I miss), my colleagues in the Biotech/Chemical arts argue much the same, for similar reasons.

    So if anything, that 50% of all adjudicated patents get invalidated means to me that attackers are not trying hard enough.

    Occasionally, I and others have suggested that someone in the government appoint a panel of expert litigators, analysts and insurers, and assign them a sample of say, 100 or 200 patents, and have them thoroughly apply their skills. I suspect, no, I know that the invalidity rate will be over 50%. The GAO really doesn’t have the qualified people to do this, even though I do like the critiques they do prepare.

    So when you write: “We can never learn from ….”, sad to say, this is one issue in the last 30 years no one has wanted to learn much about. To solve this problem would greatly erode the economics of the patent world.

  • [Avatar for F22strike]
    F22strike
    August 21, 2025 12:09 pm

    Since this article focuses on statistical analysis, what are the odds that a US patent can be successfully enforced? At least 70-80% of claims are found invalid in IPR proceedings which are typically instigated by accused infringers. Then those PTAB decisions are affirmed at a statistically high rate by the CAFC, often in Rule 36 decisions with no indication of the basis for appellate affirmance. If asserted claims somehow survive IPR proceedings, the odds of obtaining injunctive relief are extremely low due to the eBay decision by the SCOTUS. Any attempted recovery of damages for infringement is a crap shoot for the patent owner, with reasonable royalty damages being the typical limit. Thus, given the above, Big Tech and other companies have adopted the efficient infringer model which at its core is based on litigation being a far preferable alternative to licensing. Clients are not interested in esoteric statistical arguments about patent quality.

  • [Avatar for Ron Katznelson]
    Ron Katznelson
    August 21, 2025 11:26 am

    Francis: “If every patent that was allowed and was then challenged, what would the outcome be?”
    The answer is the same, as already answered in the analysis and the Figure. Part (a) of the figure assumes the prior probability of validity for all issued patents – not only for disputed patents. Most of them will not be disputed or challenged. Assume, however, that a patent from the 60 percentile (shown only in part (a)) is challenged. The opposing parties will settle because they will both conclude after investigation that the patent will be ruled valid. It will not affect the results of adjudicated patents.

    While it is true for obvious reasons that the majority of the disputed patents will be in the gray “close call” zone , if they get selected for adjudication (no settlement), about half of them will be ruled invalid.

    The important point is that we can never learn from adjudicated patents how many other issued patents are likely valid or likely invalid because they never reach adjudication, either because they are not disputed or because the dispute is settled.

  • [Avatar for Anon]
    Anon
    August 21, 2025 11:13 am

    My (small) correction:

    Patent Examination Quality instead of Patent Quality

  • [Avatar for Francis de Rege]
    Francis de Rege
    August 21, 2025 08:58 am

    Nice analysis. I do have one niggling question. Does this take into account that some patents might be invalid but are never litigated because no one (other than possibly the patent holder) cares? If every patent that was allowed and was then challenged, what would the outcome be?

Varsity Sponsors

IPWatchdog Events

Industry Events

PIUG 2026 Joint Annual and Biotechnology Conference
May 19 @ 8:00 am - May 21 @ 5:00 pm EDT
Certified Patent Valuation Analyst Training
May 28 @ 9:00 am - May 29 @ 5:00 pm EDT
2026 WIPO-U.S. Summer School on Intellectual Property
June 1 @ 9:00 am - June 12 @ 1:45 pm EDT

From IPWatchdog